Abstract
5-Aminosalicylic acid (5-ASA) enema therapy has been a direct extension of our understanding of the pharmacology and metabolism of sulfasalazine. Clinical studies have documented the efficacy and safety of topical 5-ASA therapy in distal ulcerative colitis. Future clinical experience should clarify the role of topical 5-ASA in a variety of inflammatory bowel disease syndromes.
| Original language | English (US) |
|---|---|
| Pages (from-to) | S11-S12,S13-S20 |
| Journal | Netherlands Journal of Medicine |
| Volume | 35 |
| Issue number | SUPPL. 1 |
| State | Published - Jun 1 1989 |
Keywords
- 5-Aminosalicylic acid
- Enema
- Inflammatory bowel disease
- Pharmacokinetics
ASJC Scopus subject areas
- Internal Medicine